Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

April 26, 2015 6:28 AM ET


Company Overview of Kalypsys, Inc.

Executive Profile

Paul C. Grint M.D.

Chief Medical Officer, Regulus Therapeutics Inc.
AgeTotal Calculated CompensationThis person is connected to 3 Board Members in 3 different organizations across 9 different industries.

See Board Relationships


Dr. Paul C. Grint, MD has been the Chief Medical Officer of Regulus Therapeutics Inc. since June 16, 2014. Dr. Grint joined Regulus from Cerexa, Inc., a wholly-owned subsidiary of Forest Laboratories, Inc., where he served as President and was responsible for the oversight of anti-infective product development. Prior to joining Cerexa, Dr. Grint was a Senior Vice President at Forest Research Institute, Inc., a subsidiary of Forest Laboratories, Inc. He served as the ...

Corporate Headquarters

10420 Wateridge Circle
San Diego, California 92121

United States

Phone: 858-754-3460
Fax: 858-754-3301

Board Members Memberships

Former Director and Member of Compensation Committee


Bachelor's Degree
Barts & The London School of Medicine & Dentistry, Queen Mary University of London
Saint Bartholomew Medical School, London University

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


Ali Mortazavi Chief Executive and Director
Silence Therapeutics plc
J. Michael French Chairman, Chief Executive Officer and President
Marina Biotech, Inc.
Peter French B.Sc, M.Sc, Ph.D., MBAChief Executive Officer, Managing Director and Director
Benitec Biopharma Limited
Mark W. Schwartz Ph.D.Chief Executive Officer, President, Director and Member of Ad Hoc (Strategy, Pricing, Etc) Committee
Galena Biopharma, Inc.
Mark Joseph Murray Ph.D.Chief Executive Officer, President and Director
Tekmira Pharmaceuticals Corporation
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Kalypsys, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at